| B«¬¨xª¢©M¥À¨Å÷Áý¨Å ¥x¤¤ºa¥ÁÁ`Âå°| ·s¥Í¨à¬ì ³¯¬L´f¥D¥ô (¥»¤å¸g±ÂÅvÂà¸ü¦Û³¯¬L´f¥D¥ô¤§¥À¨Å÷¨|ºô¯¸,¯S¦¹PÁÂ!!) ¥@¬É½Ã¥Í²Õ´¥þ²y¬Ì]¤Î¹w¨¾±µºØpµe(GPV)¡A¨àµ£°·±d¤Îµo®i³¡ªù(CHD)¡A©M¥Í¨|°·±d³¡ªù(RHT)¤§Áp¦X»¡©ú
«e¨¥
¡@¡@¦³Ãö÷Áý¥À¨Å¬O§_¬OB«¬¨xª¢«nªº¶Ç¬V³~®|³oÓ°ÝÃD¤w¸g«ùÄò³Q°Q½×¦n´X¦~¤F¡F÷Áý¥À¨Å«D±`«n¡A¦Ó¥þ¥@¬É¦³5%¥ª¥kªº¥À¿Ë¬OºC©ÊªºB«¬¨xª¢±aìªÌ¡A§óÅã±o¦¹Ä³ÃDªº«n©Ê¡CÀ˵ø¬ÛÃöªº¬ã¨sµoı¨S¦³ÃÒ¾Ú»¡÷Áý¥À¨Å·|¼W¥[B«¬¨xª¢±aìªÌ¶Ç¬Vªº¦MÀI©Ê¡C¥@¬É½Ã¥Í²Õ´©Ò«ØÄ³¡A¦Ó¥B¦³¤K¤QÓ°ê®a¦b°õ¦æªºÀ¦¨àB«¬¨xª¢¬Ì]±µºØ³Ì«á·|®ø°£²×¤î¶Ç¬Vªº¦MÀI©Ê¡C³oÓ¤å¥ó°Q½×÷Áý¥À¨Å¤ÎB«¬¨xª¢¦³ÃöªºÄ³ÃD¡A¨Ã¥H¥@¬É½Ã¥Í²Õ´ªº¬Ýªk´£¥X«ü«n¡C
B«¬¨xª¢¯f¬r·P¬V
¡@¡@B«¬¨xª¢¯f¬r·P¬V¬O¥@¬É©Êªº¤½¦@½Ã¥Í½ÒÃD¡A¥¦¥i¥H³y¦¨µL¯gª¬ªº·P¬V¡A¦³¯gª¬ªº«æ©Ê¨xª¢¡A²r¼É©Ê¨xª¢¡A©Î¬O«ùÄò©Êªº·P¬V¡A¤]´N¬OºC©Ê±aìªÌ¡C¥þ²y¦³¶W¹L¤T»õ¥î¤d¸UÓB«¬¨xª¢ºC©Ê±aìªÌ¡A¥L̬O°ª¦MÀI¸s¡A¥i¯àµo®i¦¨¬°ºC©Ê¬¡©Ê¨xª¢¡A¨xµw¤Æ¡A¤Îìµo©Ê¨x²ÓMÀù¯g¡C³o¼Ëªº¨Öµo¯g³y¦¨¤@¦~¶W¹L¤@¦Ê¸U¤Hªº³à¥Í¡C¬ã¨s»{¬°¡AºC©Ê±aìªÌ¤¤°ª¹F25¨ì35%ªº¤H³Ì«á·|¦º©ó³o¨Ç¨Öµo¯g¡C
B«¬¨xª¢¯f¬rªº¶Ç¬V
¡@¡@¨Ì±aìªÌªº²±¦æ²v¤£¦P¡A¶Ç¬Vªº³~®|¤]¦³¤£¦P¡C¦pªG¦a°Ï©Ê¦³°ª«ùÄòªº·P¬V®É(¥]¬AªF¨È¤Î«n¨È¡BÂÄ«¢©Ô¨Fºz¥H¤Uªº«D¬w)¡A¶Ç¬V¥Dnµo¥Í©ó©P²£´Á¥Ñ¥À¿Ë¶Çµ¹¦oªºÀ¦¨à¡A©Î¬O¨àµ£¶¡¿Ë»eªº±µÄ²(¤ô¥¶Ç¬V)¡C¦b¨È¬w¡A¥Í¨|¦~ÄÖB«¬¨xª¢±aìªÌªº°ü¤k¬ù¦³40%B«¬¨xª¢®Ö¤ß§Üì(HBeAg)¤]¶§©Ê¡A¦Ó³o¨Ç°ü¤k¦b¥Í²£«e«á¦³70¨ì90%ªº¾÷·|·P¬V¦o̪º·s¥Í¨à¡C¥Í²£«e«áªº·P¬V¥Dnµo¥Í¦b¥Í²£¤¤©Î¥Í²£«á¡AÀ¦¨à±µÄ²¨ì¥À¿Ëªº¦å²G¤Î¨ä¥LÅé²G¡C¦b¨È¬w¡A©P²£´Áªº¶Ç¬V¦û¤F±aìªÌ¤H¤f¤¤ªº25¨ì30%¡C¦b¨È¬w¤§¥~¡A¥Í¨|¦~ÄÖB«¬¨xª¢±aìªÌªº°ü¤k¬ù¦³10%ªº®Ö¤ß§Üì(HBeAg)¤]¶§©Ê¡A©P²£´Á¶Ç¬V¹ï±aìªÌ¤H¤fªº¼W¥[¸û¤£«n¡C¦b§C·P¬V°Ï(¥]¬A¦è¼Ú¤Î¥_¬ü)¡A©P²£´Áªº¶Ç¬V¸û¤£±`¨£¡F¶Ç¬V¥Dn¸g¥Ñ¦¨¤H¶¡¦å²G¤Î©Êªº±µÄ²¡CµM¦Ó¡A¦h¼Æ¤u·~¤Æ°ê®a¿zÀ˨C¤@¦ìÃh¥¥°ü¤k¬O§_¦³B«¬¨xìªí±§Üì¡A¨Ã¥H¯S§Oªº§K¬Ì²y³J¥Õ(HBIG)¤ÎB«¬¨xª¢¬Ì]ªvÀø±aìªÌ¥À¿ËªºÀ¦¨à¡C
¸g¥Ñ÷Áý¥À¨Å¶Ç¬VB«¬¨xª¢ªº¦MÀI©Ê
¡@¡@÷Áý¥À¨Å´¿³Q»{¬°¬OÀ¦¨à±o¨ìB«¬¨xª¢ªº¤@Ó¥i¯à³~®|¡A¦]¬°¦b¦³¨Ç¥À¨Å¤¤¥i¥Hµo²{¤Ö¶qªºB«¬¨xª¢ªí±§Üì¡CµM¦Ó¡A¨S¦³ÃÒ¾Ú»¡÷Áý¥À¨Å·|¼W¥[¥À¿Ë©M¨àµ£¶¡¶Ç¬Vªº¦MÀI©Ê¡C¦b¥xÆW¡A¤@Ó¬ã¨s°lÂÜ147ÓB«¬¨xª¢±aìªÌ¥À¿Ë¥Íªº¨àµ£¡Aµo²{92Ó¦Y¥À¨Åªº¨àµ£©M55Ó¦Y¤H¤u¥¤ªº¨àµ£±o¨ìB«¬¨xª¢ªº¾÷²v¤@¼Ë(4)¡C¤@Ó^°êªº¬ã¨s(5)¡A¥]¬A126Ó¹ï¶H¡A¤]µo²{±aìªÌ¥À¿ËªºÀ¦¨à¦Y¥À¨Å¤£·|¼W¥[±oB«¬¨xª¢ªº¦MÀI©Ê¡C³oÓ¬ã¨s¤¤¦³ÀËÅç¥À¿Ë®Ö¤ß§Ü쪺±¡ªp¡Aµo²{®Ö¤ß§Ü쪺±¡ªp©M¶Ç¬V²v¨S¦³Ãö«Y¡C³o¨Ç¬ã¨s±j¯P¦aªí¥Ü¡A¥À¨Å¶Ç¬Vªº¦MÀI©Ê©M¥Í²£®É±µÄ²¥À¿Ë¦å²G¤ÎÅé²Gªº°ª¦MÀI¶Ç¬V¤ñ°_¨Ó¬O¥i¥H©¿µøªº¡CµM¦Ó¡A¦³¨Ç¨x¯f±M®a¾á¤ß¦b¨Å©Ð¦³¯fÅÜ¡A¦p¨ÅÀY¥X¦å®É¡A¥i¯à·|¨ÏÀ¦¨à±µÄ²¨ì·P¬V¾¯¶qªºB«¬¨xª¢¯f¬r¡C
Á×§KB«¬¨xª¢¯f¬r««ª½¤Î¤ô¥ªº¶Ç¬V
¡@¡@±µºØB«¬¨xª¢¬Ì]¥i¥H¦³®Ä¦a¹w¨¾B«¬¨xª¢««ª½¤Î¤ô¥©Êªº¶Ç¬V¡A¹w¨¾±µºØ¥i¥HÁ×§K70¨ì90%±aìªÌ¥À¿ËªºÀ¦¨à²£¥Í«ùÄòªº±a쪬ºA¡A¨Ã¥iÁ×§K°ª¹F95%ªº¤ô¥¶Ç¬V¡C¥X¥Í«á¤G¤Q¥|¤p®É¤ºµ¹¤©B«¬¨xª¢§K¬Ì²y³J¥Õ¡A¥[¤W²Ä¤@¾¯ªºB«¬¨xª¢¬Ì]¥i¥H¼W¥[¹ï±aìªÌ¥À¿ËÀ¦¨àªº«OÅ@²v¹F85¨ì90%¡CµM¦Ó¡A¦b¶}µo¤¤°ê®a¥þ±¿zÀËÃh¥¥°ü¤kB«¬¨xª¢ªºª¬ºA©Î¬O¨Ï¥ÎB«¬¨xª¢§K¬Ì²y³J¥Õ¨Ã¤£¥i¦æ¡A¦]¦¹«ØÄ³±`³W¦aÅý©Ò¦³ªºÀ¦¨à±µºØB«¬¨xª¢¬Ì]¡C¥i¯àªº¸Ü¡A²Ä¤@¾¯¦b¥X¥Í¥|¤Q¤K¤p®É¤º±µºØ¡A¤§«á·Ó±`³Wµ¹¤©¹w¨¾±µºØ¡C¹ï©ó¦bÂå°|©Î¶E©Òªº¥Í²£¥X¥Í®Éµ¹¤©B«¬¨xª¢¬Ì]¬O¥i¯àªº¡A¦ý¬O¦pªG¬O¦b®a¸Ì¥Í²£¥i¯à´N¦³§xÃø¡C¦b¥X¥Í«áµ¹¤©¤@¾¯B«¬¨xª¢¬Ì]¦b¨È¬w¤×¬°«n¡A¦]¬°¸Ó°Ï¤§©P²£´Á¶Ç¬V«Ü±`¨£¡C¤w¸g±µºØ¹L²Ä¤@¾¯¬Ì]ªºÀ¦¨à¥i¥H¦w¥þ¦a÷Áý¥À¨Å¡C
¡@¡@¦b¨S¦³±`³W±µºØB«¬¨xª¢¬Ì]ªº¦a°Ï¡A¨Ï¥Î¥¤¶ý¤Î¤H¥¤®wªº¥À¨Å®É»Ýª`·N¡C¦h¼Æ¬y¦æ¦a°Ï«D±aìªÌªº¥À¿Ë³£´¿·P¬V¹LB«¬¨xª¢¥B¤w¸g«ì´_¡A¨Ã¥B¸g¥ÑL½L±NB«¬¨xª¢¯f¬rªº§ÜÅé¶Çµ¹À¦¨à¡A¥i¥H«OÅ@¦o̪ºÀ¦¨à¤»Ó¤ë¤º§K©ó·P¬V¡C¦b«Ü¦h¤u·~°ê®a¤¤¡A¥¤¶ý¤Î¤H¥¤®wªº¥À¨Å³£¦³¿zÀËB«¬¨xª¢ªº§Üì¡C¦pªG¶§©Êªº¸Ü¡A¦o̪º¥À¨Å¥u¯àµ¹¦Û¤vªºÀ¦¨à¦Y¡CµM¦Ó¦b¶}µo¤¤°ê®a¥i¯àµLªk°µ³o¼Ëªº¿zÀË¡C±µºØ¹LB«¬¨xª¢¬Ì]ªºÀ¦¨à¤£·|¸g¥Ñ¥¤¶ý©Î¤H¥¤®wªº¥À¨Å¤¤±o¨ìB«¬¨xª¢¡C
«ØÄ³
¡@¡@¥@¬É½Ã¥Í²Õ´«ØÄ³©Ò¦³ªºÀ¦¨à³£±µºØB«¬¨xª¢¬Ì]¡A¥i¥Hªº¸Ü²Ä¤@¾¯À³¦b¥X¥Í«á¥|¤Q¤K¤p®É¤º©ÎºÉ§Ö¦a±µºØ¡A³o¥i¥H´î¤Ö««ª½¶Ç¬V¡A¨Ã¥B°£¥h¥ô¦ó¸g¥Ñ÷Áý¥À¨Å©Î¥À¨ÅÁý¹¶Ç¬Vªº¦MÀI©Ê¡C¹w¨¾±µºØ¤]¥i¥HÁ×§KB«¬¨xª¢©Ò¦³¨ä¥L¤è¦¡ªº¶Ç¬V¡C
¡@¡@¥@¬É½Ã¥Í²Õ´¤ÎÁp¦X°ê¨àµ£°òª÷·|«ØÄ³©Ò¦³ªºÀ¦¨àÀ³§¹¥þ÷Áý¥À¨Å¥|¨ì¤»Ó¤ë¡A¨Ã¦b²K¥[¾A·íªº©TÅ鹪««á¡A«ùÄò÷Áý¥À¨Å¨ì¨â·³©Î¨â·³¥H¤W¡C¨S¦³÷Áý¥À¨ÅªºÀ¦¨à·|¦³¬Û·íªº¿©¯f²v¤Î¦º¤`²v¡C¨S¦³ÃÒ¾Ú»¡B«¬¨xª¢±aìªÌ¥À¿Ë÷Áý¥À¨Å·|¼W¥[¶Ç¬Vµ¹À¦¨àªº¾÷·|¡A§Y¨Ï¬O¨S¦³±µºØ¬Ì]¡C¦]¦¹¡A§Y¨Ï¦bB«¬¨xª¢°ª¬y¦æ°Ï¤Î¨S¦³±µºØB«¬¨xª¢¬Ì]ªº¦a°Ï¡A¥À¨Å÷Áý¤´¬O«ØÄ³ªºÀ¦¨à÷Áý¤è¦¡¡C
°Ñ¦Ò¤åÄm
1. Global control of Hepatitis B through vaccination: Role of Hepatitis B vaccine in the Expanded Programme on Immunization, Maynard JE, Kane MA and Hadler SC, Rev Inf Dis 1989;11(suppl 3):574-578
2. Protocol for assessing prevalence of Hepatitis B infection in antenatal patients, World Health organization, WHO/EPI/GEN/90.6
3. Protection against viral hepatitis, Recommendations of Immunization Practices Advisory Committee(ACIP_, MMWR 1990;39(no S-2)
4. Evidence against breastfeeding as a mechanism for vertical transmission of Hepatitis B, Beasley PR, Shiao I-S, Stevens CE, Meng H-C, Lancet 1975;ii:740-41
5. Vertical transmission of hepatitis B surface antigen in carrier mothers in two west London hospitals, Woo D, Davies PA, Harvey DR,Hurley R, Waterson AP, Arch Child Dis, 1979;54:670-75
6. Prevention of perinatally transmitted Hepatitis B virus infections with Hepatitis B Immune globulin and Hepatitis B vaccine, Beasley PR,Hwang LY, Lee GCY,et al. Lancet 1983;ii:1099-102
7. Prevention of the HbsAg carrier state in newborn infants of mothers who are chronic carriers of HbsAg and HbeAg by administration of Hepatitis B vaccine and hepatitis B immunoglobulin, Wong VCW,IP HMH, Reesink HW,et al. Lancet 1984;1:921-6
8. Breastfeeding babies of HbsAg-positive mothers, Tseng AKY, Lam CWK, Tam J. Lancet 1988;ii:1032
|